* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *
Full Coverage

FDA seeks black box warning for epilepsy drugs

07-Jul-2008
Story Timeline:  97 days

WASHINGTON (Reuters) - U.S. Food and Drug Administration officials will seek a strong "black box" warning for epilepsy drugs cautioning about the risk of suicidal thoughts and behavior, an agency spokeswoman told Reuters on Monday. "We are going to ask for a boxed warning on these drugs," said FDA spokeswoman Sandy Walsh. The news comes ahead of an FDA advisory panel meeting on Thursday to discuss the drugs' risks. The FDA plans to seek comment from its outside advisers on the proposed warning, Walsh said. GlaxoSmithKline Plc's Lamictal and Pfizer Inc's Lyrica are among the top-selling epilepsy drugs. Others include Johnson & Johnson's Topamax and Abbott Laboratories Inc's Depakote. (Reporting by Susan Heavey; editing by John Wallace) Next Article: FACTBOX-Details of Fed, SEC investment bank... [read full story]                    

Add Comment
Latest article on this story:

U.S. panel rejects strong epilepsy drug warning

reutershealth.com 11-Jul-2008
First article on this story:

FDA seeks black box warning for epilepsy drugs

reuters.com 07-Jul-2008
Selected publications with coverage of this story:
RELATED
1 2 3 4 5 next »